Clinical significance of EGFR, Her-2 and EGF in oral squamous cell carcinoma: A case control study

Journal of Experimental and Clinical Cancer Research

Volumn 29, Issue 1, 2010, Pages

  Bernardes, Vanessa F ^a   Gleber Netto, Frederico O ^a   Sousa, Sílvia F ^a   Silva, Tarcília A ^a   Aguiar, Maria Cássia F ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER GRADING; CANCER RADIOTHERAPY; CANCER STAGING; CARCINOGENESIS; CASE CONTROL STUDY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; MALE; MOUTH SQUAMOUS CELL CARCINOMA; ORAL SURGERY; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SALIVA LEVEL; SMOKING; ADOLESCENT; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; METABOLISM; MIDDLE AGED; MOUTH TUMOR; SALIVA; SQUAMOUS CELL CARCINOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; EPIDERMAL GROWTH FACTOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; SALIVA;

EID: 77951592932     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-29-40     Document Type: Article

References (34)

1. Erman M: Molecular mechanisms of signal transduction: epidermal growth factor receptor family, vascular endothelial growth factor family, Kit, platelet-derived growth factor receptor, Ras. J BUON 2007, 12(Suppl 1): 83-94.
2. McInnes C, Sykes BD: Growth factor receptors: structure, mechanism, and drug discovery. Biopolymers 1997, 43:339-366.
3. Laimer K, Spizzo G, Gastl G, Obrist P, Brunhuber T, Fong D, Barbieri V, Jank S, Doppler W, Rasse M, Norer B: High EGFR expression predicts poor prognosis in patients with squamous cell carcinoma of the oral cavity and oropharynx: A TMA-based immunohistochemical analysis. Oral Oncol 2007, 43: 193-198.
4. Rautava J, Jee KJ, Miettinen PJ, Nagy B, Myllykangas S, Odell EW, Soukka T, Morgan PR, Heikinheimo K: ERBB receptors in developing, dysplastic and malignant oral epithelia. Oral Oncol 2008, 44:227-235.
5. Hoffmann TK, Ballo H, Braunstein S, Van Lierop A, Wagenmann M, Bier H: Serum level and tissue expression of c-erbB-1 and c-erbB-2 protooncogene products in patients with squamous cell carcinoma of the head and neck. Oral Oncol 2001, 37:50-56.
6. Gokhale AS, Haddad RI, Cavacini LA, Wirth L, Weeks L, Hallar M, Faucher J, Posner MR: Serum concentrations of interleukin-8, vascular endothelial growth factor, and epidermal growth factor receptor in patients with squamous cell cancer of the head and neck. Oral Oncol 2005, 41:70-76.
7. Balicki R, Grabowska SZ, Citko A: Salivary epidermal growth factor in oral cavity cancer. Oral Oncol 2005, 41:48-55.
8. Harari PM, Allen GW, Bonner JA: Biology of interactions: Antiepidermal growth factor receptor agents. J Clin Oncol 2007, 25:4057-4065.
9. Ohnishi Y, Lieger O, Attygalla M, Iizuka T, Kakudo K: Effects of epidermal growth factor on the invasion activity of the oral cancer cell lines HSC3 and SAS. Oral Oncol 2008, 44:1155-1159.
10. Moreno-Lopez LA, Esparza-Gomez GC, Gonzalez-Navarro A, Cerero- Lapiedra R, Gonzalez-Hernandez MJ, Dominguez-Rojas V: Risk of oral cancer associated with tobacco smoking, alcohol consumption and oral hygiene: A case-control study in Madrid, Spain. Oral Oncol 2000, 36:170-174.
11. Bryne M, Koppang HS, Lilleng R, Stene T, Bang G, Dabelsteen E: New malignancy grading is a better prognostic indicator than Broders' grading in oral squamous cell carcinomas. J Oral Pathol Med 1989, 18: 432-437.
12. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
13. Diniz-Freitas M, Garcia-Caballero T, Antunez-Lopez J, Gandara-Rey JM, Garcia-Garcia A: Pharmacodiagnostic evaluation of EGFR expression in oral squamous cell carcinoma. Oral Dis 2007, 13: 285-290.
14. Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, Dowsett M, Fitzgibbons PL, Hanna WM, Langer A, et al: American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 2007, 25:118-145.
15. Lip and oral cavity. American Joint Committee on Cancer: AJCC Cancer Staging Manual New York: Springer, 6 2002, 23-32.
16. Hamakawa H, Nakashiro K, Sumida T, Shintani S, Myers JN, Takes RP, Rinaldo A, Ferlito A: Basic evidence of molecular targeted therapy for oral cancer and salivary gland cancer. Head Neck 2008, 30: 800-809.
17. O-charoenrat P, Rhys-Evans PH, Modjtahedi H, Eccles SA: The role of c- erbB receptors and ligands in head and neck squamous cell carcinoma. Oral Oncol 2002, 38:627-640.
18. Rogers SJ, Harrington KJ, Rhys-Evans PPOC, Eccles SA: Biological significance of c-erbB family oncogenes in head and neck cancer. Cancer Metastasis Rev 2005, 24: 47-69.
19. Katoh K, Nakanishi Y, Akimoto S, Yoshimura K, Takagi M, Sakamoto M, Hirohashi S: Correlation between laminin-5 gamma2 chain expression and epidermal growth factor receptor expression and its clinicopathological significance in squamous cell carcinoma of the tongue. Oncology 2002, 62:318-326.
20. Ulanovski D, Stern Y, Roizman P, Shpitzer T, Popovtzer A, Feinmesser R: Expression of EGFR and Cerb-B2 as prognostic factors in cancer of the tongue. Oral Oncol 2004, 40:532-537.
21. Fong Y, Chou SJ, Hung KF, Wu HT, Kao SY: An investigation of the differential expression of Her2/neu gene expression in normal oral mucosa, epithelial dysplasia, and oral squamous cell carcinoma in Taiwan. J Chin Med Assoc 2008, 71:123-127.
22. Khan AJ, King BL, Smith BD, Smith GL, DiGiovanna MP, Carter D, Haffty BG: Characterization of the HER-2/neu oncogene by immunohistochemical and fluorescence in situ hybridization analysis in oral and oropharyngeal squamous cell carcinoma. Clin Cancer Res 2002, 8:540-548.
23. Yamada T, Takagi M, Shioda S: Evaluation of epidermal growth factor receptor in squamous cell carcinoma of the oral cavity. Oral Surg Oral Med Oral Pathol 1992, 73:67-70.
24. Breuer B, Smith S, Thor A, Edgerton S, Osborne MP, Minick R, Cody HS, Nowak E, Cortese A, Simmons RM, et al: ErbB-2 protein in sera and tumors of breast cancer patients. Breast Cancer Res Treat 1998, 49:261-270.
25. Leitzel K, Teramoto Y, Sampson E, Mauceri J, Langton BC, Demers L, Podczaski E, Harvey H, Shambaugh S, Volas G, et al: Elevated soluble c- erbB-2 antigen levels in the serum and effusions of a proportion of breast cancer patients. J Clin Oncol 1992, 10:1436-1443.
26. Leary AF, Hanna WM, Vijver van de MJ, Penault-Llorca F, Ruschoff J, Osamura RY, Bilous M, Dowsett M: Value and limitations of measuring HER-2 extracellular domain in the serum of breast cancer patients. J C lin Oncol 2009, 27:1694-1705.
27. Werkmeister R, Brandt B, Joos U: Clinical relevance of erbB-1 and -2 oncogenes in oral carcinomas. Oral Oncol 2000, 36:100-105.
28. Partanen R, Hemminki K, Koskinen H, Luo JC, Carney WP, Brandt-Rauf PW: The detection of increased amounts of the extracellular domain of the epidermal growth factor receptor in serum during carcinogenesis in asbestosis patients. J Occup Med 1994, 36:1324-1328.
29. Groschl M: The physiological role of hormones in saliva. Bioessays 2009, 31:843-852.
30. Carney WP, Neumann R, Lipton A, Leitzel K, Ali S, Price CP: Potential clinical utility of serum HER-2/neu oncoprotein concentrations in patients with breast cancer. Clin Chem 2003, 49:1579-1598.
31. Lemos-Gonzalez Y, Rodriguez-Berrocal FJ, Cordero OJ, Gomez C, Paez de la Cadena M: Alteration of the serum levels of the epidermal growth factor receptor and its ligands in patients with non-small cell lung cancer and head and neck carcinoma. Br J Cancer 2007, 96:1569-1578.
32. De Witt AE, Dong JY, Wiley HS, Lauffenburger DA: Quantitative analysis of the EGF receptor autocrine system reveals cryptic regulation of cell response by ligand capture. J Cell Sci 2001, 114: 2301-2313.
33. Ino M, Ushiro K, Ino C, Yamashita T, Kumazawa T: Kinetics of epidermal growth factor in saliva. Acta Otolaryngol Suppl 1993, 500:126-130.
34. Normanno N, De Luca A, Bianco C, Strizzi L, Mancino M, Maiello MR, Carotenuto A, De Feo G, Caponigro F, Salomon DS: Epidermal growth factor receptor (EGFR) signaling in cancer. Gene 2006, 366: 2-16.